The Latest Developments at Triskelion

High-Concentration

High-Concentration Biologics Are Redefining Subcutaneous Delivery

Pharma's Almanac

Drug Delivery

Intracellular Delivery: Reaching Targets Beyond the Cell Surface

David Alvaro, Ph.D.

Pharma's Almanac

Next-Gen Delivery

Beyond Lipid Nanoparticles: The Search for Next-Generation Delivery Platforms

Pharma's Almanac

LAIs

The Long View: How Extended-Duration Therapies Are Reshaping Patient Care

Pharma's Almanac

LNP Strategy

Building Better RNA Medicines Through Smarter LNP Formulation Strategy

Aula Al Muslim, Ph.D.

Recipharm Advanced Bio

Pathfinder

Depot Injection vs. Implantable Drug Delivery: Which Long-Acting Delivery Strategy Is Better?

Pharma's Almanac

CRO Partnerships

Building Resilient Development Models: How Mid-Size Pharma Can Scale Without Losing Control

Brian Healey

IQVIA

Outsourcing

The Hidden Operational Costs of Multi-Vendor Outsourcing Models

Pharma's Almanac

Peptides

The Resurgence of Peptide Drugs in the Age of Precision Medicine

David Alvaro, Ph.D.

Pharma's Almanac

Oligo Delivery

Expanding the Reach of Oligonucleotide Drugs Through Delivery Innovation

David Alvaro, Ph.D.

Pharma's Almanac

Oral mAbs

Oral Delivery of Monoclonal Antibodies: The Pursuit Continues

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Neuro CMC

Producing Therapies for the Brain: Manufacturing and Formulation Challenges for CNS Biologics

David Alvaro, Ph.D.

Pharma's Almanac